What Actually Happens in a Sleep Study (and What a Normal Result Doesn't Rule Out)

Written by the Nuvirox Research Team

Short answer: it is far less unpleasant than people fear, and less conclusive than people hope. A sleep study attaches sensors to your scalp, face, chest, finger and legs, records you through a night, and produces a report dominated by one number: how many times per hour your breathing was disrupted. That number is excellent at answering one question and largely silent on several others. Knowing what is measured — and what a clean result does and does not rule out — is the difference between a useful test and a frustrating one.

What actually gets attached to you?

A full in-lab study, properly called polysomnography, layers several recordings at once. Small electrodes glued to the scalp record brain waves, which is the only way to score sleep stages properly. Electrodes near the eyes track eye movement, and one under the chin records muscle tone — together those three let a technologist distinguish REM from light non-REM sleep. Elastic belts around the chest and abdomen record breathing effort, a nasal cannula and thermal sensor record airflow, a fingertip probe records oxygen saturation, adhesive electrodes record heart rhythm, and sensors on the shins record leg movements.

Nothing pierces the skin, nothing hurts, and you can usually get up to use the bathroom by calling the technologist. The genuine complaint is that sleeping in a strange room while wired to a box is not representative of your normal night — the well-documented first-night effect. Sleep laboratories know this and interpret accordingly, but it is a real limitation, not a fussy objection.

Home test or lab study — which one will I get?

The American Academy of Sleep Medicine's diagnostic guideline is fairly clear on this. Both polysomnography and home sleep apnea testing with a technically adequate device are considered diagnostic for uncomplicated adults who present with signs and symptoms suggesting an increased risk of moderate to severe obstructive sleep apnea. Questionnaires and prediction tools alone are not.

But there are firm exceptions. The guideline recommends in-lab polysomnography rather than a home test for people with significant cardiorespiratory disease, potential respiratory muscle weakness from a neuromuscular condition, awake hypoventilation or suspected sleep-related hypoventilation, chronic opioid use, a history of stroke, or severe insomnia. It also recommends that if a single home test comes back negative, inconclusive or technically inadequate, polysomnography should follow — a point worth remembering if you are told your home test was fine and left there.

Simplified comparison; home device capability varies by type. The lab-only rows are why a home test can confirm sleep apnea but cannot rule out much else.

What does the report actually say?

The headline is the apnea-hypopnea index, or AHI: the average number of complete breathing pauses and partial reductions per hour of sleep. Conventionally, under 5 is normal, 5 to 15 mild, 15 to 30 moderate and above 30 severe. You will usually also see oxygen saturation figures, total sleep time and efficiency, a breakdown of sleep stages, an arousal index, and a periodic limb movement index.

Two cautions about reading it yourself. First, the sleep-stage percentages come from a single night in an unfamiliar bed and should not be over-interpreted. Second, and more importantly, the AHI is a count of events meeting specific scoring definitions. Breathing disturbance that does not meet those definitions can still fragment your sleep, and it will not appear in the headline number.

What human studies actually show

There is a recognised pattern of people whose airflow is limited enough to wake them repeatedly without meeting apnea thresholds. Upper airway resistance syndrome was described by Guilleminault and colleagues in the early 1990s in adults with excessive daytime sleepiness and unremarkable standard polysomnography. Oesophageal pressure monitoring revealed repetitive increases in breathing effort ending in brief arousals — now called respiratory effort-related arousals, or RERAs. One working definition is an AHI under 5, oxygen saturation at or above 92%, and a RERA index of at least 5 per hour.

The daytime cost appears comparable to mild sleep apnea. A study of 115 people — 34 with upper airway resistance syndrome, 47 with mild obstructive sleep apnea and 34 controls, matched for age, sex, body mass index and education — assessed sustained attention with the psychomotor vigilance task five times across a day. The comparison of interest was not with healthy controls but with the mild apnea group, and the finding was that the resistance-syndrome patients did not come out looking better.

The honest counterweight: this category remains genuinely contested. The AASM does not classify upper airway resistance syndrome as separate from obstructive sleep apnea, treating it as part of the same spectrum involving RERAs. Diagnostic criteria vary between research groups, oesophageal manometry is invasive and rarely used, and there is no consensus cut-off validated against long-term outcomes. So the fair reading is that airflow limitation below apnea thresholds is real and can cause symptoms — and that the label, the threshold and the testing standard are all still being argued about.

My study was normal and I am still exhausted

This is common enough to deserve a systematic response rather than resignation. First, ask which test you had and whether a RERA or respiratory disturbance index was scored at all — many home tests do not measure the respiratory effort needed to detect them. Second, ask whether the guideline's recommendation about repeating a negative or inconclusive home test with in-lab polysomnography applies to you.

Then broaden the differential, because unrefreshing sleep has causes a breathing study was never going to find: iron deficiency and restless legs, thyroid disease, depression, medication effects, circadian misalignment, chronic pain, and central disorders of hypersomnolence. We went through several of these in why you wake up tired, and the specific hypersomnia picture in idiopathic hypersomnia. Sleep apnea in women is also under-recognised because the presentation often differs from the textbook version, which we covered in sleep apnea symptoms in women.

How to make the night go better

Practical things that genuinely help: keep your normal caffeine and alcohol pattern rather than dramatically changing it, since the study is meant to represent a typical night; skip afternoon naps so you arrive with normal sleep pressure; wash and dry your hair without conditioner or product so the electrodes stick; bring your own pillow if you use a specific one; and tell the technologist about any regular medication, because withdrawal effects can distort results.

Do not start or stop a sleep supplement in the week before a study without telling the ordering clinician. Melatonin, sedating antihistamines and herbal formulas can all shift sleep architecture, and a study performed under an unusual chemical influence answers a question nobody asked.

Frequently asked questions

What if I cannot fall asleep in the lab? Most people sleep less and worse than usual, and technologists expect it. A study can usually be scored from a few hours of recording. If you truly do not sleep, it may be repeated.

Can I roll over with all the wires on? Yes. The leads are bundled to allow position changes, and body position is itself a recorded variable because some people only obstruct on their back.

How long do results take? Typically one to three weeks. A technologist scores the recording epoch by epoch first, then a physician interprets it in the context of your history.

Is a home test worse? Not worse — narrower. For an uncomplicated adult with a high likelihood of moderate to severe obstructive sleep apnea, it answers the question efficiently. For anyone with the comorbidities named in the guideline, or a negative result and persistent symptoms, the lab study is the appropriate next step.

From Nuvirox

Why we formulated Sleep+ Restore.

If a clinician has ruled out the medical drivers above and you are looking at general sleep support, this is what we make and what is in it.

• 10 mg melatonin — a circadian timing signal. Published trials mostly use 0.3–5 mg, so 10 mg sits above the studied range for many people; that is a reason to start low and to talk to your prescriber first.
• 905 mg Sleep Formula blend — L-tryptophan, L-theanine, chamomile, lemon balm, passionflower, hops, ashwagandha, Chinese skullcap, goji, GABA, taurine, inositol, St. John's Wort and 5-HTP.
• Vitamin B6, calcium, magnesium — pathway cofactors at nutritional amounts.
• 60-day money-back guarantee.

Please read this part. This formula contains St. John's Wort, which induces the CYP3A4 enzyme system and can lower blood levels of many prescription drugs, and 5-HTP, which raises serotonin-syndrome risk alongside antidepressants and other serotonergic medicines. If you take prescription medication for the condition described in this article, clear this — or any sleep supplement — with your prescriber or pharmacist before you start. That is not a formality. It is the single most important sentence on this page.

Learn more about Sleep+ Restore →

The bottom line

A sleep study is a good test with a specific scope. It is very good at finding obstructive sleep apnea, reasonably good at spotting periodic limb movements, and structurally poor at explaining fatigue that comes from anywhere else. If yours came back normal and you still feel wrecked, the useful next move is not another supplement. It is asking your clinician what the study measured, what it did not, and what the next test should be.

References

1. Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, Harrod CG. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2017;13(3):479–504.
2. Upper Airway Resistance Syndrome. StatPearls. NCBI Bookshelf NBK564402.
3. Palombini LO, Tufik S, Rapoport DM, et al. Upper airway resistance syndrome patients have worse sleep quality compared to mild obstructive sleep apnea. PLOS ONE. 2016;11(5):e0156244. doi:10.1371/journal.pone.0156244
4. Guilleminault C, Kim YD, Chowdhuri S, Horita M, Ohayon M, Kushida C. Sleep and daytime sleepiness in upper airway resistance syndrome compared to obstructive sleep apnoea syndrome. European Respiratory Journal. 2001;17(5):838–847. PMID: 11488314
5. Stoohs RA, Philip P, Andries D, Finlayson EV, Guilleminault C. Reaction time performance in upper airway resistance syndrome versus obstructive sleep apnea syndrome. Sleep Medicine. 2009;10(9):1000–1004. PMID: 19410510
6. American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 3. Darien, IL: AASM; 2023.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.